Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children

被引:48
作者
Charron, P
Dubourg, O
Desnos, M
Bouhour, JB
Isnard, R
Hagege, A
Carrier, L
Bonne, G
Tesson, F
Richard, P
Hainque, B
Schwartz, K
Komajda, M
机构
[1] Hop La Pitie Salpetriere, Serv Cardiol, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, INSERM, U153, F-75651 Paris, France
[3] Hop La Pitie Salpetriere, Serv Biochim, F-75651 Paris 13, France
[4] Hop Ambroise Pare, Serv Cardiol, Boulogne, France
[5] Hop Boucicaut, Serv Cardiol, Paris, France
[6] Hop Laennec, Serv Cardiol, Nantes, France
关键词
hypertrophic cardiomyopathy; children; diagnosis; genetics;
D O I
10.1053/euhj.1998.1049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The aim of the study was to evaluate electrocardiography and echocardiography in the diagnosis of familial hypertrophic cardiomyopathy in children, using the genetic status as the criterion of reference. Methods and Results We analysed 35 children (<18 years) from 13 families with identified mutations: 16 were genetically affected (11.2+/-3 years), 19 unaffected (13.1 +/- 2.8 years). Conventional major diagnostic criteria were: left ventricular wall thickness >95% confidence interval on the echocardiogram; abnormal Q waves, left ventricular hypertrophy (voltage >95th percentile), or marked ST-T changes on the electrocardiogram. Twenty-two minor electrocardiographic and echocardiographic criteria were also analysed. Using major criteria, the specificity of the electrocardiogram and echocardiogram was excellent (100% for both) but sensitivity was particularly low (38% and 50% respectively). However, when four relevant additional criteria (QRS axis, left atrium dimension, intraventricular septum/posterior wall ratio, E/A wave ratio) were taken into account, sensitivity increased to 88% and specificity remained high (95%). Conclusions (1) Familial hypertrophic cardiomyopathy was diagnosed in only similar to 50% of genetically affected children by conventional electrocardiographic and/or echocardiographic criteria. (2) Relevant additional diagnostic criteria were selected so that nearly all children considered as healthy carriers of a mutation (based on conventional criteria) could be identified with excellent specificity.
引用
收藏
页码:1377 / 1382
页数:6
相关论文
共 17 条
  • [1] CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    BONNE, G
    CARRIER, L
    BERCOVICI, J
    CRUAUD, C
    RICHARD, P
    HAINQUE, B
    GAUTEL, M
    LABEIT, S
    JAMES, M
    BECKMANN, J
    WEISSENBACH, J
    VOSBERG, HP
    FISZMAN, M
    KOMAJDA, M
    SCHWARTZ, K
    [J]. NATURE GENETICS, 1995, 11 (04) : 438 - 440
  • [2] Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy
    Carrier, L
    Bonne, G
    Bahrend, E
    Yu, B
    Richard, P
    Niel, F
    Hainque, B
    Cruaud, C
    Gary, F
    Labeit, S
    Bouhour, JB
    Dubourg, O
    Desnos, M
    Hagege, AA
    Trent, RJ
    Komajda, M
    Fiszman, M
    Schwartz, K
    [J]. CIRCULATION RESEARCH, 1997, 80 (03) : 427 - 434
  • [3] Charron P, 1997, CIRCULATION, V96, P214
  • [4] Charron P, 1997, GENET COUNSEL, V8, P107
  • [5] FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - MICROSATELLITE HAPLOTYPING AND IDENTIFICATION OF A HOT-SPOT FOR MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE
    DAUSSE, E
    KOMAJDA, M
    FETLER, L
    DUBOURG, O
    DUFOUR, C
    CARRIER, L
    WISNEWSKY, C
    BERCOVICI, J
    HENGSTENBERG, C
    ALMAHDAWI, S
    ISNARD, R
    HAGEGE, A
    BOUHOUR, JB
    DESNOS, M
    BECKMANN, J
    WEISSENBACH, J
    SCHWARTZ, K
    GUICHENEY, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2807 - 2813
  • [6] DAVIGNON A, 1979, PEDIATR CARDIOL, V1, P123
  • [7] FLAVIGNY J, IN PRESS J MOL MED
  • [8] ECHOCARDIOGRAPHIC MEASUREMENTS IN NORMAL SUBJECTS FROM INFANCY TO OLD-AGE
    HENRY, WL
    GARDIN, JM
    WARE, JH
    [J]. CIRCULATION, 1980, 62 (05) : 1054 - 1061
  • [9] HYPERTROPHIC CARDIOMYOPATHY - INTERRELATIONS OF CLINICAL MANIFESTATIONS, PATHOPHYSIOLOGY, AND THERAPY .1.
    MARON, BJ
    BONOW, RO
    CANNON, RO
    LEON, MB
    EPSTEIN, SE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) : 780 - 789
  • [10] DEVELOPMENT AND PROGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
    MARON, BJ
    SPIRITO, P
    WESLEY, Y
    ARCE, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (10) : 610 - 614